Xavier Rose Mary, Vorderstrasse Allison
Rose Mary Xavier, MS, RN, PMHNP-BC, is PhD Student; Allison Vorderstrasse, DNSc, APRN, FAAN, is Associate Professor, Duke University School of Nursing, Durham, North Carolina.
Nurs Res. 2016 May-Jun;65(3):224-37. doi: 10.1097/NNR.0000000000000159.
Insight in schizophrenia is defined as awareness into illness, symptoms, and need for treatment and has long been associated with cognition, other psychopathological symptoms, and several adverse clinical and functional outcomes. However, the biological basis of insight is not clearly understood.
The aim of this systematic review was to critically evaluate and summarize advances in the study of the biological basis of insight in schizophrenia and to identify gaps in this knowledge.
A literature search of PubMed, CINAHL, PsycINFO, and EMBASE databases was conducted using search terms to identify articles relevant to the biology of insight in schizophrenia published in the last 6 years. Articles that focused on etiology of insight in schizophrenia and those that examined the neurobiology of insight in schizophrenia or psychoses were chosen for analysis. Articles on insight in conditions other than schizophrenia or psychoses and which did not investigate the neurobiological underpinnings of insight were excluded from the review.
Twenty-six articles met the inclusion criteria for this review. Of the 26 articles, 3 focused on cellular abnormalities and 23 were neuroimaging studies. Preliminary data identify the prefrontal cortex, cingulate cortex, and regions of the temporal and parietal lobe (precuneus, inferior parietal lobule) and hippocampus as the neural correlates of insight.
A growing body of literature attests to the neurobiological basis of insight in schizophrenia. Current evidence supports the neurobiological basis of insight in schizophrenia and identifies specific neural correlates for insight types and its dimensions. Further studies that examine the precise biological mechanisms of insight are needed to apply this knowledge to effective clinical intervention development.
精神分裂症的自知力被定义为对疾病、症状及治疗需求的认识,长期以来一直与认知、其他精神病理症状以及多种不良临床和功能结局相关。然而,自知力的生物学基础尚不清楚。
本系统评价的目的是批判性地评估和总结精神分裂症自知力生物学基础研究的进展,并找出这方面知识的空白。
使用检索词对PubMed、CINAHL、PsycINFO和EMBASE数据库进行文献检索,以识别过去6年发表的与精神分裂症自知力生物学相关的文章。选择关注精神分裂症自知力病因以及研究精神分裂症或精神病自知力神经生物学的文章进行分析。排除关于精神分裂症或精神病以外情况的自知力且未研究自知力神经生物学基础的文章。
26篇文章符合本评价的纳入标准。在这26篇文章中,3篇关注细胞异常,23篇为神经影像学研究。初步数据确定前额叶皮质、扣带回皮质以及颞叶和顶叶区域(楔前叶、顶下小叶)和海马体为自知力的神经关联。
越来越多的文献证明精神分裂症自知力存在神经生物学基础。目前的证据支持精神分裂症自知力的神经生物学基础,并确定了自知力类型及其维度的特定神经关联。需要进一步研究自知力的确切生物学机制,以便将这些知识应用于有效的临床干预开发。